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The problem of how cells make rapid but orderly transi- 
tions between different phases of the cell cycle has fasci- 
nated biologists since they first observed mitosis late in 
the nineteenth century. Physiological experiments first 
suggested that progress through particular phases of the 
cell cycle might depend on the accumulation of critical 
"periodic" proteins, and the discovery that cyclin B accu- 
mulates during interphase of embryonic cell cycles later 
provided a molecular candidate for the inducer of mitosis. 
In addition, the disappearance of cyclin at the end of mito- 
sis suggested the novel possibility that the destruction of 
particular proteins is needed to progress from one stage 
of the cell cycle to the next (Evans et al., 1983). 
We now know that both of these ideas are true. An appro- 
priately phosphorylated complex of Cdc2 (the prototypic 
member of the cyclin-dependent kinase family) and cyclin 
B is an active protein kinase (often called M phase-pro- 
moting factor [MPF]) that can induce mitosis. Molecular 
dissection of cyclin B revealed the existence of the destruc- 
tion box, a short amino acid sequence near the N-ter- 
minus that targets the protein for destruction at the transi- 
tion between metaphase and anaphase (Glotzer et al., 
1991). Removing the destruction box makes cyclin inde- 
structible and reveals that cyclin destruction is required 
for many of the events that occur as cells leave mitosis 
(Murray et al., 1989). These events include chromosome 
decondensation, nuclear envelope reformation (in bigger 
eukaryotes), and cytokinesis, but not sister chromatid seg- 
regation, which can still occur in cells (Surana et al., 1993) 
or extracts (Holloway et al., 1993) that have high levels 
of cyclin B. In contrast, fragments of cyclin that contain 
the destruction box slow down both endogenous cyclin B 
destruction and sister chromatid separation, suggesting 
that some unknown protein involved in the linkage of sister 
chromatids must be destroyed by the same machinery 
that destroys cyclin B (Holloway et al., 1993). 
How do cells destroy cyclin B, and how is destruction 
regulated so that in 1 or 2 min the half-life of cyclin falls 
from more than 1 hr to less than 1 min? The short answer 
is ubiquitin-mediated proteolysis (Glotzer et al., 1991; 
Hershko et al., 1991), a process that has been biochemi- 
cally well understood for several years, but whose biologi- 
cal function was unclear. In this complex reaction, several 
molecules of the small protein ubiquitin are attached to 
a lysine on the substrate protein, thus directing it to the 
proteasome, a complex proteolytic machine that degrades 
the polyubiquitinated protein into small peptides (reviewed 
by Ciechanover, 1994). Ubiquitin-mediated proteolysis is 
hierarchical (see Figure 1). The first enzyme in the path- 
way, El, uses the energy of ATP hydrolysis to form a 
thioester bond between itself and a ubiquitin molecule. 
This complex then reacts with one of many different E2 
enzymes, transferring the bound ubiquitin from E1 to E2. 
The final transfer of ubiquitin to the protein substrate can 
be mediated by an E2 alone or by an E2 acting in concert 
with an E3. In the latter situation, it is not yet clear whether 
the ubiquitin is passed from E2 to E3 to target protein or 
whether the E3 acts to bring the E2 and target protein 
close to each other. 
The regulation of cyclin proteolysis takes at least two 
forms: a temporal one that imposes a minimum lag be- 
tween the activation of MPF and the activation of cyclin 
destruction, and a cell cycle checkpoint hat prevents the 
destruction of cyclin B in cells that have not yet assembled 
a functional spindle (Minshull et al., 1994). The develop- 
ment of fractionated systems that can ubiquitinate cyclin 
(Hershko et al., 1994; King et al., 1995 [this issue of Cell]) 
and the identification of the specific E2 and E3 enzymes 
required for this reaction are the first steps toward under- 
standing how the destruction of cyclin B and the hypotheti- 
cal sister cohesion protein are controlled. 
Like much of our knowledge about the cell cycle, the 
recent information about cyclin proteolysis comes from 
combining genetics and biochemistry. Genetic analysis 
was complicated because cells must satisfy two conditions 
to leave mitosis: the spindle must be properly assembled, 
and the cyclin proteolysis machinery must be activated. 
Thus ,although mutants that damage the cyclin destruc- 
tion apparatus would arrest in mitosis, this phenotype 
could also be due to lesions in the spindle that prevent 
cyclin destruction by activating the spindle assembly 
checkpoint. Irniger et al. (1995 [this issue of Cell]) elegantly 
circumvented this problem by capitalizing on the observa- 
tion that cyclin B destruction in budding yeast is active 
from the onset of anaphase until the cells pass START; 
the point in G 1 that commits them to DNA synthesis (Amon 
et al., 1994). By placing cyclin B synthesis under the con- 
trol of an inducible promoter and arresting cells before 
START, they were able to identify temperature-sensitive 
mutations in three genes that stabilized cyclin B. Two of 
these, cdc16 and cdc23, represent new alleles of genes 
that had been identified in Hartwell's original screen for 
cell cycle mutants. Since the original mutants and the new 
alleles all arrest in metaphase, CDC16 and CDC23 are 
likely to be required for the destruction of sister chromatid 
cohesion proteins as well as cyclin B. If cdc23 cells are 
genetically tricked into entering mitosis with unreplicated 
DNA, the spindle elongates and the chromatin separates 
into two masses (Irniger et al., 1995). This work reinforces 
the earlier conclusion that it is sister chromatid separation, 
rather than MPF inactivation, that induces the transition 
between metaphase and anaphase (Holloway et al., 1993). 
Without linkage to a sister, a chromosome cannot achieve 
a position midway between the two spindle poles, the 
length of the spindle cannot be restrained, and the spindle 
eventually breaks in two. 
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Figure 1. The Biochemistry ofCyclin Destruction 
See text for further details. U represents ubiquitin. 
CDC16 and CDC23 are members of the tetratricopep- 
tide repeat family of proteins, named after the characteris- 
tic presence of several copies of a loosely conserved 34 
amino acid repeat. Genetic and physical evidence sug- 
gests that three members of this family, CDC16, CDC23, 
and CDC27, exist together as a large complex whose pres- 
ence is required for the rnetaphase to anaphase transition 
(Lamb et al., 1994). The small size and poor cytology of 
budding yeast make determining the localization of these 
proteins difficult. The pace of genome sequencing offers 
a simple solution to this problem: find a homolog in an 
organism with bigger cells and better cytology. This strat- 
egy revealed human homologs of CDC16 and CDC27, and 
antibodies to the human proteins stain the spindle poles 
and microtubules (Tugendreich et al., 1995 [this issue of 
Cell]). Injecting anti-CDC27 antibodies into interphase 
cells arrests them in metaphase of their next mitosis. In. 
jecting metaphase cells also prevents the onset of ana- 
phase, suggesting that the antibody blocks a late step in 
the reactions that induce cyclin B destruction. Injection of 
anti-CDC16 antibodies has no effect. Although this dis- 
crepancy may reflect differences in the strength of the 
antibodies, it is consistent with observations from budding 
yeast, in which some cdc16 alleles cannot block cyclin 
degradation in G1, even though they do arrest cells in 
metaphase (Irniger et al., 1995). 
Why should components required for cyclin destruction 
be physically associated with the spindle? In the earliest 
cell cycles of the fly embryo, there is no obvious global 
destruction of cyclin B at the end of metaphase, although 
cycles of abundance do become visible as the density of 
nuclei increases (Edgar et al., 1994). One interpretation 
of these observations is that in this organism the presence 
of a spindle locally concentrates the destruction machin- 
ery to a point where the rate of cyclin destruction exceeds 
new synthesis, thus triggering local destruction. This is 
an appealing model for an organism with no membranes 
between nuclei, since it could allow adjacent spindles 
some independence from each other in the timing of ana- 
phase. In contrast, frog egg extracts can globally destroy 
cyclin B in the absence of both spindle poles and microtu- 
bules (Minshull et al., 1994). This difference probably re- 
flects the very different life cycles of frogs and flies. Frog 
eggs are enormous cells that physically divide, requiring 
that MPF be inactivated at the cleavage furrow, hundreds 
of microns away from the spindle, whereas early fly em- 
bryos lack cytokinesis and thus do not need to inactivate 
MPF anywhere other than around the nuclei. The ability 
of fly nuclei to replicate their DNA while swimming in a 
cytoplasmic sea of MPF suggests that MPF activity in the 
nucleus and cytoplasm can be independently regulated. 
The direct biochemical approach to cyclin B ubiquitina- 
tion was initiated by Hershko et al. (1994), who fractionated 
mitotic clam egg extracts that would specifically degrade 
cyclin B. They showed that the ubiquitination activity could 
be separated into three components: El, an E2, and a 
large complex that was needed to allow the other two en- 
zymes to add ubiquitin to cyclin B and that therefore meets 
the definition of an E3 (Sudakin et. al, 1995). By preparing 
the different factors from either interphase or mitotic ex- 
tracts, Hershko et al. (1994) showed that the activity of 
the large complex varied between interphase and mitosis, 
but that of the E1 and E2 did not. King et al. (1995) adopted 
the same approach, using frog egg extracts to fractionate 
Minireview 
151 
the activities needed for cyclin B ubiquitination into El, 
either of two E2s, and a large E3 complex whose activity 
differs between interphase and mitosis. Treating extracts 
with anti-CDC27 antibodies can deplete the large com- 
plex, and material immunoprecipitated from complete ex- 
tracts by these antibodies can substitute for the large com- 
plex. Unfortunately, since this material has not yet been 
fully purified, it is impossible to know what else the E3 
complex contains in addition to CDC27 and CDC16. 
Which E2s are responsible for conjugating ubiquitin to 
cyclin B? Biochemistry and genetics give conflicting an- 
swers. One of the E2s identified in frog eggs reacts with 
antibodies to the human homolog of a yeast E2 called 
UBC4 (King et al., 1995). But, although there is a genetic 
interaction between ubc4 and cdc23 mutations (Irniger et 
al., 1995), removing both UBC4 and its close relative 
UBC5 fails to arrest budding yeast in mitosis (Seufert and 
Jentsch, 1990). In contrast, the temperature-sensitive 
ubc9 mutation arrests cells in G2 or mitosis (the two stages 
are not morphologically distinguishable in budding yeast) 
and prevents cyclin B destruction in Gl-arrested cells 
(Seufert et al., 1995). Although a variety of complicated 
models can accommodate all these observations, further 
experiments are clearly required to determine which E2s 
are the physiological mediators of cyclin B destruction. 
Although the biochemical and genetic dissection of 
cyclin B destruction has identified important players in this 
complicated reaction, it raises a number of questions. At 
the mechanistic level, how does the CDC16- and CDC27- 
containing E3 complex stimulate cyclin ubiquitination, and 
how is the activity of this complex regulated during the 
cell cycle? More importantly, how is the activity of this 
complex controlled, and what role does this control play 
in the physiological regulation of proteolysis? The discrete 
lag between the activation of M PF and cyclin B destruction 
suggests that MPF acts indirectly to activate the CDC16- 
CDC27 complex, thus guaranteeing cells that lack an ef- 
fective spindle assembly checkpoint (such as early frog 
embryos) a brief period for spindle assembly before the 
onset of anaphase. Three lines of evidence suggest that 
cell cycle regulation occurs at the level of cyclin itself, in 
addition to changes in the activity of ubiquitinating en- 
zymes. First, even though the same activities catalyze the 
destruction of both cyclin B and the S phase cyclin, cyclin 
A (Sudakin et al., 1995), the in vivo degradation of cyclin 
A precedes that of cyclin B, and the spindle assembly 
checkpoint can protect cyclin B but not cyclin A (Hunt 
et al., 1992; Minshull et al., 1994; Whitfield et al., 1990). 
Second, certain cyclins can be degraded only if they are 
physically associated with Cdc2 (Stewart et al., 1994). 
Third, kinases that are activated by the spindle assembly 
checkpoint can phosphorylate cyclin B, although so far this 
reaction has only been demonstrated under very artificial 
conditions (Minshull et al., 1994). Deciphering regulation 
at the level of cyclin and determining the relative impor- 
tance of modifications on the ubiquitination machinery 
compared with those on its substrates will probably require 
another dive into the murk of crude cell cycle extracts. 
How general a mechanism is proteolysis for regulating 
biology? One of the first genetically understood examples 
of induction, the activation of lysogenic bacteriophages, 
depends on the proteolytic destruction of the phage re- 
pressor. Despite this lesson and the abundant regulatory 
possibilities that the complexity of ubiquitin-mediated pro- 
teolysis offers, eukaryotic biology is just starting to dis- 
cover the richness and ubiquity of control by regulated 
proteolysis. One emerging principle, which follows the 
original paradigm of phage induction, is that ubiquitin- 
mediated proteolysis often produces its effects by destroy- 
ing repressors. Thus, anaphase appears to require the 
destruction of a protein that somehow prevents the sepa- 
ration of sister chromatids, and the transition from G1 to 
S phase in budding yeast is dependent on ubiquitin- 
mediated proteolysis of a protein that inhibits the activity 
of complexes between CDC28 and S phase cyclins 
(Schwob et al., 1994). Dissection of the genes that papillo- 
maviruses use to transform mammalian cells reveals that 
one of the viral gene products (E6) recruits a cellular factor 
that acts as an E3 to stimulate the destruction of p53, 
which can act as a repressor of the G1 to S transition 
(Scheffner et al., 1993). In the immune system, a wide 
range of stimuli leads to the nuclear localization of a tran- 
scriptional activator (NF-KB) by inducing the ubiquitin- 
dependent proteolysis of a binding protein (IF-KB) that 
keeps it in the cytoplasm (Palombella et al., 1994), and 
homologs of this system are used in the control of dorsal- 
ventral polarity in the fly embryo (Whalen and Steward, 
1993). In other circumstances, ubiquitin-mediated proteol- 
ysis can be used to remove activating signals. In plants the 
activated form of phytochrome that mediates the diverse 
responses to long wavelength light is subject to ubiquitin- 
mediated proteolysis, whereas the inactive form is not 
(Jabben et al., 1989). This scheme allows plants to re- 
spond rapidly to darkness by quickly removing the active 
phytochrome and to respond to light by activating the sta- 
ble but inactive form of the phytochrome. The wide range 
of these examples suggests that, like Cdk-cyclin com- 
plexes, the combinatorial possibilities of E2s and E3s al- 
lowed evolution to diversify an invention into so many dif- 
ferent areas of regulation that we will be uncovering new 
ones until well into the twenty-first century. 
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